Have you heard that the FDA recently approved two new medications for appetite suppression?

Have you heard that the FDA recently approved two new medications for appetite suppression? They are not yet available, but here is the "word" on them, from the FDA blog: "In clinical testing prior to approval, compared with lifestyle mod

ification alone, patients treated with Belviq plus lifestyle modification had an average weight loss of about 3.5% and patients treated with Qsymia plus lifestyle modification averaged weight loss of approximately 6% to 9%. Although these results are a step in the right direction, there are a few important things to keep in mind about these products.First, if you’re looking to lose a few pounds before going to the beach or after over- indulging on vacation, these drugs are not for you…one aspect of their use not highlighted by the media is that these drugs are intended for chronic use as part of a comprehensive weight loss program that includes modifications to diet and increased exercise. Obesity is a chronic disease, similar to diabetes or high blood pressure, and requires long-term treatment… among other adverse effects, Qsymia can cause birth defects and Belviq can cause a dangerous chemical imbalance called “serotonin syndrome.” Doctors and patients who are considering the use of these drugs as part of an individualized weight management program must carefully consider the potential benefits and the potential risks…”